n-methyladenosine has been researched along with Uterine Cervical Neoplasms in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 7 (87.50) | 2.80 |
| Authors | Studies |
|---|---|
| Han, C; Kong, W; Li, J; Liu, T; Song, D; Zhang, H; Zhao, X | 1 |
| Chen, CB; Chen, J; Li, L; Lin, X; Lin, YB; Liu, J; Wang, F; Xu, Q | 1 |
| Condic, M; Egger, EK; Ellinger, J; Klümper, N; Kristiansen, G; Mustea, A; Qureischi, M; Ralser, DJ; Thiesler, T | 1 |
| Cao, M; Hao, S; Jia, H; Wang, J | 1 |
| Huang, Y; Wang, Q; Zhang, J; Zhang, Q | 1 |
| Gao, Z; Guo, X; Ji, M; Li, L; Liu, J; Su, X; Wang, Q | 1 |
| Chen, Z; Deng, L; Li, Y; Liang, Z; Ling, K; Zhu, Y | 1 |
| Bai, ZL; Wang, YY; Xia, D; Zhao, R; Zhao, ZJ; Zhe, H; Zhou, S | 1 |
8 other study(ies) available for n-methyladenosine and Uterine Cervical Neoplasms
| Article | Year |
|---|---|
N6-Methyladenosine-Related lncRNAs as potential biomarkers for predicting prognoses and immune responses in patients with cervical cancer.
Topics: Adenosine; Biomarkers, Tumor; Epigenesis, Genetic; Female; Humans; Immunity; Prognosis; RNA, Long Noncoding; Tumor Microenvironment; Uterine Cervical Neoplasms | 2022 |
N
Topics: Adenosine; Animals; beta Catenin; DNA-Binding Proteins; Drug Resistance, Neoplasm; Female; Humans; Mice; Neoplasm Recurrence, Local; Nuclear Proteins; RNA-Binding Proteins; RNA, Messenger; Tumor Suppressor Protein p53; Uterine Cervical Neoplasms | 2022 |
Comprehensive Analysis of N6-Methyladenosine (m6A) Writers, Erasers, and Readers in Cervical Cancer.
Topics: Adenosine; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Female; Humans; Methyltransferases; RNA Processing, Post-Transcriptional; RNA, Messenger; Uterine Cervical Neoplasms | 2022 |
Prediction of prognosis, immune infiltration and immunotherapy response with N6-methyladenosine-related lncRNA clustering patterns in cervical cancer.
Topics: Adenosine; Cluster Analysis; Female; Humans; Immunotherapy; Interleukin-10; Prognosis; RNA, Long Noncoding; Transforming Growth Factor beta1; Tumor Microenvironment; Uterine Cervical Neoplasms | 2022 |
m
Topics: Adenosine; Biomarkers, Tumor; Cell Movement; Cell Proliferation; Female; HeLa Cells; Humans; Methyltransferases; Ovarian Neoplasms; Uterine Cervical Neoplasms | 2020 |
N
Topics: Adenosine; Animals; Carcinogenesis; Cell Line, Tumor; Cell Proliferation; Female; Heterografts; Hexokinase; Humans; Male; Methyltransferases; Mice; Mice, Inbred BALB C; Mice, Nude; Middle Aged; Prognosis; RNA-Binding Proteins; Transfection; Uterine Cervical Neoplasms; Warburg Effect, Oncologic | 2020 |
circ0000069 promotes cervical cancer cell proliferation and migration by inhibiting miR-4426.
Topics: Adenosine; Base Sequence; Carcinogenesis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Female; Humans; Oncogenes; RNA Stability; RNA, Circular; Uterine Cervical Neoplasms | 2021 |
FTO regulates the chemo-radiotherapy resistance of cervical squamous cell carcinoma (CSCC) by targeting β-catenin through mRNA demethylation.
Topics: Adenosine; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Animals; beta Catenin; Carcinoma, Squamous Cell; Cell Line, Tumor; Chemoradiotherapy; Demethylation; DNA-Binding Proteins; Drug Resistance, Neoplasm; Endonucleases; Female; Humans; Mice; Neoplasm Transplantation; Prognosis; Radiation Tolerance; Survival Analysis; Up-Regulation; Uterine Cervical Neoplasms | 2018 |